Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

697 Press Releases
DateTitleCompany
23 May 16 CHAMPIX® (varenicline) European Union Label Updated to Include New Safety and Efficacy Data from the EAGLES Clinical Trial Following Endorsement from CHMP Pfizer Inc.,
Published by
Business Wire
19 May 16 Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting Pfizer, Merck ,
Published by
PharmiWeb.com
16 May 16 Pfizer to Acquire Anacor Pfizer Inc.,
Published by
Business Wire
11 May 16 Pfizer Awards More Than $1 Million in Metastatic Breast Cancer Research Funding Through Breast Cancer: A Story Half Told Initiative Pfizer Inc.,
Published by
Business Wire
10 May 16 Health Canada approves new first-line treatment for women living with metastatic breast cancer Pfizer Canada Inc.,
Published by
PR Newswire
29 Apr 16 Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrollednounces Enrollment of First Patient in the OPTIMA Study in China Pfizer ,
Published by
PharmiWeb.com
26 Apr 16 Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled Pfizer Inc.,
Published by
Business Wire
26 Apr 16 Pfizer Invites Public to Listen to Webcast of April 28 Annual Meeting of Shareholders Pfizer ,
Published by
PharmiWeb.com
08 Apr 16 Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s Disease Care Pfizer ,
Published by
PharmiWeb.com
07 Apr 16 Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s Disease Care Pfizer Inc.,
Published by
Business Wire
06 Apr 16 Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13® Pfizer Inc.,
Published by
Business Wire
06 Apr 16 Pfizer Announces Termination of Proposed Combination with Allergan Pfizer Inc.,
Published by
Business Wire
05 Apr 16 FDA Approves INFLECTRA™ (Biosimilar Infliximab), The First U.S. Biosimilar Monoclonal Antibody, For All Eligible Indications Pfizer Inc.,
Published by
Business Wire
01 Apr 16 Pfizer and Allergan Receive Request for Additional Information from Federal Trade Commission Regarding Proposed Combination Pfizer ,
Published by
PharmiWeb.com
01 Apr 16 Pfizer Announces Positive Topline Results from Second Phase 3 Lipid-Lowering Study Evaluating Bococizumab Pfizer Inc.,
Published by
Business Wire
31 Mar 16 Pfizer Inc. (NYSE: PFE) today issued the following statement: Pfizer Inc.,
Published by
Business Wire
29 Mar 16 Pfizer Joins The Human Vaccines Project To Help Decode The Immune System Pfizer ,
Published by
PharmiWeb.com
29 Mar 16 Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts Pfizer ,
Published by
PharmiWeb.com
08 Mar 16 Pfizer Announces Publication of Study Results of BeneFIX® Coagulation Factor IX (Recombinant) Once-Weekly Prophylaxis for Hemophilia B Pfizer Inc.,
Published by
Business Wire
10 Feb 16 Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications Pfizer Inc.,
Published by
Business Wire
16 Feb 16 WYETH REACHES AGREEMENT IN PRINCIPLE TO RESOLVE MEDICAID DRUG REBATE CLAIMS FOR 2001-2006 PERIOD FOR PROTONIX Pfizer,
Published by
Business Wire
22 Mar 16 Pfizer Joins The Human Vaccines Project To Help Decode The Immune System Pfizer Inc.,
Published by
Business Wire
16 Mar 16 Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory Bowel Disease at the 11th Congress of ECCO Pfizer Inc.,
Published by
Business Wire
24 Feb 16 Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
26 Feb 16 Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis Pfizer ,
Published by
PharmiWeb.com
15 Mar 16 Pfizer Celebrates a Year of Achievements in 2015 Annual Review Pfizer Inc.,
Published by
Business Wire
25 Mar 16 Pfizer Announces European Medicines Agency Accepted for Review Its Marketing Authorization Application for XELJANZ® (Tofacitinib Citrate) for the Treatment of Moderate to Severe Rheumatoid Arthritis Pfizer ,
Published by
PharmiWeb.com
15 Jan 16 Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations Pfizer ,
Published by
PharmiWeb.com
24 Jan 16 PFIZER CANADA CONGRATULATES THE ONTARIO GOVERNMENT FOR IMMUNIZATION 2020 STRATEGY PFIZER CANADA ,
Published by
PharmiWeb.com
04 Feb 16 PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2014 RESULTS; PROVIDES 2015 FINANCIAL GUIDANCE PFIZER ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.